Prophylaxis of Thrombosis With Implantable Devices for Central Venous Access in Cancer Patients
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
This is a Phase III open-labed, multicenter, prospective, randomised study, and comparative
3-arms of 140 patients (i.e. 420 total patients).
Study period (date of first inclusion/last inclusion): 3 years Treatment period : 3 months